Delivery Order SPE2DB22D1017-SPE2DB25FYPCJ
Award Date 8/25/25
Potential Completion Date 9/16/25
Potential Value $9.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $9,296.97 to AmerisourceBergen Drug Corp for the supply of Tavalisse 150 mg tablets (60-count) on August 15, 2025, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a $9,266.70 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Tavalisse 100 mg on August 5, 2025, with completion targeted for August 26, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a ceiling value of $18,533.40. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) under a firm fixed-price contract valued at $9,266.70. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- This is a delivery order under a larger contract vehicle awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for $8,549.70 to provide Tavalisse 150 mg tablets. The order has a firm fixed price and a completion date of September 26, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a...
- This federal contract award, valued at $9,266.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TAVALISSE 100 MG TABLET 60S, a pharmaceutical product, with a completion date of June 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,266.70, is for the delivery of TAVALISSE 100 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $9,266.70 and runs through March 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $10,218.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 capsules of Tavneos 10 mg, a pharmaceutical product for federal medical supply needs. This non-competitive delivery order, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAVALISSE 150 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $9,296.97 and a period of performance through May 5, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- The Defense Logistics Agency awarded a $27,926.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for TALVEY 40 mg/mL vials, with an ultimate completion date of September 2, 2025. This non-set-aside competitive award, issued on August 11, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive...